Why is Werewolf Therapeutics, Inc. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
-6.29%
EBIT to Interest (avg)
-35.10
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.12
Sales to Capital Employed (avg)
0.09
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
74.81%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.11
EV to EBIT
0.00
EV to EBITDA
EV to Capital Employed
0.05
EV to Sales
-0.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1104.53%
ROE (Latest)
-127.93%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
2What is working for the Company
NET PROFIT(HY)
Higher at USD -36.26 MM
-10What is not working for the Company
NET PROFIT(9M)
At USD -60 MM has Grown at -45.54%
OPERATING CASH FLOW(Y)
Lowest at USD -60.82 MM
ROCE(HY)
Lowest at -100.55%
RAW MATERIAL COST(Y)
Grown by 101.69% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 0 times
Here's what is working for Werewolf Therapeutics, Inc.
Net Profit
Higher at USD -36.26 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Here's what is not working for Werewolf Therapeutics, Inc.
Operating Cash Flow
Lowest at USD -60.82 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Debtors Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 101.69% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






